Todd Brady

Track

Insider profile

Currently holds positions in Evoke Pharma Inc, Outlook Therapeutics Inc and Aldeyra Therapeutics Inc

Performance

Overall performance
1.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 53% 68% 82%
Transactions
9 78% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -34%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Director Evoke Pharma Inc June 1, 2007 -
Independent Director Outlook Therapeutics Inc Sept. 1, 2014 -
President, Chief Executive Officer, Director Aldeyra Therapeutics Inc Jan. 23, 2012 -
Director Aldeyra Therapeutics Inc Jan. 1, 2005 - Jan. 22, 2012
Todd Brady's trades of Aldeyra Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
3.25
Quantity 183,238
Value US$595,524
Transaction date
Purchase
Price
6.03
Quantity 3,000 +0.5%
Value US$18,090
Transaction date
Purchase
Price
5.79
Quantity 10,000 +1.7%
Value US$57,900
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-03
B Purchase
60,662 +19.0%
64.64
US$77,464 		60,662 +19.0% 64.64 US$77,464
2026-06-05 2026-06-03
B Purchase
71,629 -0.6%
285.15
US$3,114,534 		71,629 -0.6% 285.15 US$3,114,534
2024-03-12 2024-03-12
S Sale
81,461 -48.6%
104.73
US$2,174,034 		81,461 -48.6% 104.73 US$2,174,034
2024-03-12 2024-03-11
S Sale
97,914 -5.9%
3.27
US$320,521 		97,914 -5.9% 3.27 US$320,521
2024-03-11 2024-03-11
PrS Proposed sale
183,238
3.25
US$595,524 		183,238 3.25 US$595,524
2022-06-27 2022-06-23
B Purchase
17,700 +1.5%
3.36
US$59,546 		17,700 +1.5% 3.36 US$59,546
2019-10-02 2019-09-30
PP Planned purchase
8,710 +1.4%
5.68
US$49,483 		8,710 +1.4% 5.68 US$49,483
2019-09-25 2019-09-23
PP Planned purchase
8,680 +1.4%
5.81
US$50,433 		8,680 +1.4% 5.81 US$50,433
2019-09-20 2019-09-18
B Purchase
14,288 +2.4%
5.91
US$84,465 		14,288 +2.4% 5.91 US$84,465
2019-09-17 2019-09-16
B Purchase
3,000 +0.5%
6.03
US$18,090 		3,000 +0.5% 6.03 US$18,090
2019-09-17 2019-09-13
B Purchase
10,000 +1.7%
5.79
US$57,900 		10,000 +1.7% 5.79 US$57,900
2019-09-11 2019-09-10
B Purchase
10,000 +1.8%
5.39
US$53,937 		10,000 +1.8% 5.39 US$53,937
2019-09-11 2019-09-09
PP Planned purchase
10,000 +1.8%
4.89
US$48,887 		10,000 +1.8% 4.89 US$48,887